GPX4 and cancer: A key finding in this direction is that cancer cells with a more de‐differentiated, mesenchymal phenotype are dependent on GPX4 for their survival and, consequently, more sensitive to ferroptosis triggered by GPX4 inhibition than their more differentiated counterparts (Hangauer et al, 2017; Viswanathan et al, 2017).